by Tom Barrett | Apr 1, 2016 | Employer Issues, General Health, General Insurance Issues, Health Policy, Healthcare Issues, Healthcare Reform, Managed Care - Group Health, National News, News and Events, Pharmacy Costs, Pharmacy, PBMs and Pharma Costs, Providers, Uncategorized
There’s a lot in the news these days about what’s referred to as the opioid crisis or epidemic. Just yesterday for instance — highly respected healthcare consultant (and close friend) Joe Paduda, fresh off of speaking at a national drug summit in Atlanta, wrote...
by Mike Barrett | Feb 8, 2016 | Employer Issues, Health Policy, Healthcare Issues, Healthcare Reform, Managed Care - Group Health, Pharmacy Costs, Pharmacy, PBMs and Pharma Costs, Providers, Uncategorized
We are finding some crazy Rx trends that are translating into real world cost and care issues for our clients and their employees. Here’s a prime example. We recently found that a type 2 diabetes drug (GLUMETZA) increased in cost by 900%, nearly overnight. After...
by Tom Barrett | Jan 5, 2016 | General Health, General Insurance Issues, Health Policy, Healthcare Issues, Healthcare Reform, Pharmacy Costs, Pharmacy, PBMs and Pharma Costs, Providers
It seems the kickoff of a New Year fosters predictions, Top Ten’s, and various and sundry industry-related crystal ball lists. An article about consumer healthcare trends in this morning’s Fiscal Times (10 Healthcare Trends That Will Affect You in 2016) caught my eye....
by Tom Barrett | Dec 10, 2014 | Employer Issues, General Health, General Insurance Issues, Medicare Medicaid, Pharmacy Costs
…Here are the ABC’s (and Part D) For whatever reason – aging workforce, increasing costs, heightened awareness because of ACA – we’re getting lots and lots of questions from clients and their employees about Medicare this year. Way more than in years past. The...
by BBGAdmin | May 9, 2014 | Employer Issues, General Health, Pharmacy Costs
An article about big pharma companies and their pricing policies show a trend toward sharply rising drug prices. It doesn’t seem likely that it will slow down any time soon. I warn you – there’s tons of details to consider when it comes to...
